Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
dextroamphetamine sulfate
|
| gptkbp:ATCCode |
N06BA02
|
| gptkbp:contraindication |
hypertension
glaucoma hyperthyroidism history of drug abuse advanced arteriosclerosis symptomatic cardiovascular disease |
| gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_II
|
| gptkbp:FDAApproved |
yes
|
| gptkbp:firstApprovalUS |
2006
|
| gptkbp:form |
oral solution
|
| https://www.w3.org/2000/01/rdf-schema#label |
ProCentra
|
| gptkbp:indication |
gptkb:attention_deficit_hyperactivity_disorder
narcolepsy |
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Tris_Pharma
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
anxiety
loss of appetite increased heart rate insomnia dry mouth |
| gptkbp:bfsParent |
gptkb:dextroamphetamine
|
| gptkbp:bfsLayer |
7
|